1. Lihana RW, Khamadi SA, Lubano K, Mwangi J, Kinyua JG, Okoth VO, Lagat NJ, Okoth FA, Songok EM, Makokha EP: Genetic characterization of HIV Type 1 among patients with suspected immune reconstitution inflammatory syndrome after initiation of antiretroviral therapy in Kenya. AIDS Res Hum Retroviruses. 2010, 26 (7): 833-898. 10.1089/aid.2009.0229.
2. Monleau M, Faihun F, Affolabi D, Angnihoun A, Boillot F, Anagonou S, Peeters M, Delaporte E: Antiretroviral drug resistance in HIV-1 infected patients receiving antiretroviral treatment in routine clinics in Cotonou, Benin. J AIDS HIV Res. 2011, 3 (6): 114-120.
3. Nyamache AK, Muigai WT, Nganga Z, Khamadi SA: HIV-1 genetic diversity and naturally occurring polymorphisms in HIV-1 Kenyan isolates: implications for integrase inhibitors. AIDS Res Hum Retroviruses. 2012, 28 (8): 933-936. 10.1089/aid.2011.0122.
4. National AIDS and STI Control Programme (NASCOP): Kenya HIV drug resistance Country report. [cited 29 July 2014]; available from http://nascop.or.ke/library/ART%20guidelines/Final_HIV_DR_Report_2010_2011.pdf
5. National AIDS and STI Control Programme (NASCOP): Guidelines for antiretroviral therapy in Kenya. 2011, [cited 29 July 2014]; Available from:http://nascop.or.ke/library/artconference/Kenya_Treatment_Guidelines.pdf